Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tag: FDA


The limitations of progression-free survival as an endpoint – NPR addresses


Sour apples in land of Oz as FDA rips his apple juice fear-mongering


FDA publishes “Communicating Risks & Benefits: An Evidence-Based User’s Guide”


Laurel & Hardy and prostate cancer chemoprevention


Concerns over FDA loosening conflict of interest rules


“Think Inside the Box” – call for plain English facts labels about Rx drugs


Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer


7 health news web gems to wrap up the week